I agree that this site is using cookies. You can find further informations here.
X
Ciruelos E
146  results:
Search for persons X
?
1

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  3 - p. 102388 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Prognostic value of intrinsic subtypes in hormone-receptor-..:

Schettini, F. ; Martínez-Sáez, O. ; Falato, C....
ESMO Open.  8 (2023)  3 - p. 101214 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Patritumab deruxtecan in untreated hormone receptor-positiv..:

Oliveira, M. ; Falato, C. ; Cejalvo, J.M....
Annals of Oncology.  34 (2023)  8 - p. 670-680 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Final results from the PERUSE study of first-line pertuzuma..:

Miles, D. ; Ciruelos, E. ; Schneeweiss, A....
Annals of Oncology.  32 (2021)  10 - p. 1245-1255 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Is number of sentinel nodes enougth after neoadjuvant chemo..:

Aragón, S. ; Oliver, R. ; Tabuenca, M.J...
The Breast.  56 (2021)  - p. S74-S75 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Factors Associated With Extrapulmonary Tuberculosis in Spai..:

Luque, Lydia ; Rodrigo, Teresa ; García-García, José María...
Open Respiratory Archives.  2 (2020)  3 - p. 119-126 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Everolimus plus exemestane in hormone-receptor-positive, HE..:

Ciruelos, E. ; Jerusalem, G. ; Martin, M....
Clinical and Translational Oncology.  22 (2020)  10 - p. 1857-1866 , 2020
Link: https://doi.org/10.1007/..
 
?
8

Impact of BMI on the outcome of metastatic breast cancer pa..:

Corona, S. ; Giudici, F. ; Jerusalem, G....
European Journal of Cancer.  138 (2020)  - p. S67 , 2020
Link: https://doi.org/10.1016/..
 
?
9

A retrospective, multicenter study of the efficacy of lapat..:

Gavilá, J. ; De La Haba, J. ; Bermejo, B....
Clinical and Translational Oncology.  22 (2019)  3 - p. 420-428 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Correction to: Biomarkers in breast cancer: A consensus sta..:

Colomer, R. ; Aranda-López, I. ; Albanell, J....
Clinical and Translational Oncology.  20 (2018)  8 - p. 1093-1095 , 2018
Link: https://doi.org/10.1007/..
 
?
11

PAM50 intrinsic subtype in hormone receptor-positive (HR+)/..:

Prat, A. ; Brase, J.C. ; Cheng, Y....
European Journal of Cancer.  92 (2018)  - p. S117-S118 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-ne..:

Kaufman, P.A. ; Pernas, S. ; Martin, M....
European Journal of Cancer.  92 (2018)  - p. S117-S118 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Metastatic or locally advanced breast cancer patients: towa..:

on behalf of the MACBETH Group ; Cazzaniga, Marina E. ; Ciruelos, E....
Cancer Chemotherapy and Pharmacology.  83 (2018)  2 - p. 301-318 , 2018
Link: https://doi.org/10.1007/..
 
?
14

PCN20 - CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPRO..:

Ciruelos, E. ; Alba, E. ; Lopez, R....
Value in Health.  21 (2018)  - p. S18 , 2018
Link: https://doi.org/10.1016/..
 
?
15

SEOM clinical guidelines in early stage breast cancer (2018:

Ayala de la Peña, F. ; Andrés, R. ; Garcia-Sáenz, J. A....
Clinical and Translational Oncology.  21 (2018)  1 - p. 18-30 , 2018
Link: https://doi.org/10.1007/..
 
1-15